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INTRODUCTION
Diabetic foot is considered to be one of the most serious
complications for patients suffering from Diabetes Mellitus
(DM). Approximately 20–25% of all diabetic patients will
present with lower extremity ulceration at some time in
their lives. Diabetic foot is the leading cause of non-
traumatic lower limb amputations in the world, resulting
in an amputation risk for diabetic patients that is
approximately 40 times greater than that of the general
population. Post-amputation mortality is extremely high,
with a three-year survival rate of 65% and a five-year
survival rate of 41%. It is a health issue affecting several
countries and represents a significant socioeconomic
problem.
1-4 In Brazil, amputation, admission, ulceration,
and cost data are similar to other Western countries.
5-7
Recognition of individuals at risk for ulceration, followed
by adequate intervention, may reduce the chance of
unfavorable results up to 80%.
8
Peripheral sensory-motor neuropathy, which is respon-
sible for the progressive loss of protective and proprio-
ceptive sensations, is considered the main agent of the
clinical abnormalities found in diabetic foot patients. It is
important to consider that in the final phases of the disease
the patient may present with a completely insensitive
foot.
9,10 One of the first studies looking to improve touch
sensitivity screening dates back to 1898 and used a
horsehair attached to a thorn.
11 This method was refined
and currently a 10g nylon monofilament, developed by
Semmes and Weinstein, is accepted as the gold standard
for detecting ulcer risk.
12 Its reproducibility and predictive
value lead the World Health Organization (WHO) and the
International Diabetes Federation (IDF) to recommend its
use in clinical practice.
1,2
In 2006, Bourcier et al. showed the effectiveness of the
‘‘house made’’ monofilament, constructed from a fishing
line, for screening for diabetic foot. The main characteristic
of this line is that it exerts a 10 g pressure when bent (4 cm
length by 500 mm diameter N˚ M-1425, South Bend Inc.
North Brook, EUA).
13 In Brazil, the 10 g monofilament is
produced locally, but is not always available for purchase.
The objective of this study was to identify a similar nylon
line and compare it to the commercially available one.
METHODOLOGY
This was a prospective, investigative, non-interventionist
study with minimal risk to the participants. It was approved
by the Local Ethics in Research Committee (CAPPesq n˚
1184/09) and informed consent was obtained from all
subjects who agreed to participate.
The study consisted of three phases. Initially, we assessed
the fishing lines available in the national market that presented
bending characteristics similar to the 10 g monofilament. If
possible, we identified lines that did not require any other
device for clinical use, i.e. the only holding structures could be
the thumb and index finger of the examiner. This step was
done inside the laboratory using a precision digital scale
(OHAUS Max model – capacity =210 g/d=1 mg).
In the second phase, we evaluated the chosen line,
referred to here as the ‘‘white-line’’, in relation to the
commercially available (SORRI-BAURU), referred to here
as the ‘‘yellow-line’’. We proceeded with the clinical
evaluation of this filament in 100 healthy (56 male and 44
female), non-diabetic medical students and physicians
from the State University of Sao Paulo who volunteered
for the study. The diabetes criteria used to select this group
followed the ADA (American Diabetes Association) dia-
betes diagnosis criteria. To exclude the presence of
abnormalities in lower limb sensations in this group, all
individuals submitted to a clinical evaluation using
vibration perception (128 Hz tuning fork) at two sites
(hallux pulp and malleolus) and point pressure (Semmes-
Weinstein 10 g monofilament) at five sites (halux, 3
rd toe,
1
st,3
rd,a n d5
th metatarsal heads). No individuals presented
with any kind of insensitivity.
Evaluation with the new monofilament was compared to
the commercially available monofilament. Subjects were
evaluated in the sitting position. Each filament was initially
applied to the back of the hand so that it could be identified
and then randomly applied to the foot sole at the following
sites (3 times each): halux, 3
rd toe, 1
st,3
rd,a n d5
th
metatarsal heads. Individuals were asked to close their
eyes and identify which filament was being used at each
time.
The third phase was carried out in two distinct diabetic
foot reference units (Diabetic Foot Unit, Endocrinology and
Metabolism Division at the State University of Sa ˜o Paulo
and the Medical Specialties Centre of Aracaju-CEMAR). We
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1105invited 190 diabetic subjects (80 male and 110 female) with a
history of at least 5 years of disease (according to the ADA
diabetes diagnosis criteria) to participate in this study. One
hundred of the subjects had a previous diagnosis of clinical
diabetic neuropathy and 90 did not. One patient declined to
participate. All patients were re-examined to confirm their
diagnosis and no discordance with the cited criteria was
found.
The neuropathy criteria used in both diabetic foot units
were the absence of vibration perception (128 Hz tuning
fork) in at least one site (hallux pulp and/or malleolus),
insensitivity to plantar point pressure (Semmes-Weinstein
10 g monofilament in at least one of seven sites), ankle reflex
reduction, and/or absent answer.
2 We again evaluated both
filaments, as described above. Answers were recorded as
present/absent.
Data from phases 2 and 3 was organized into tables of
contingency and analyzed by the Chi-Square method after
Pearson’s correction. Significance value was fixed at 5%. The
kappa coefficient was used as a measure of inter-annotator
agreement for qualitative (categorical) items. Kappa coeffi-
cient was expected to be equal to 1 if the 2 evaluation
methods were in complete agreement.
RESULTS
Phase 1: We initially investigated the physical character-
istics of lines with diameters and raw materials that allowed
compression in ‘‘grams’’. There were 6 lines that fulfilled
such criteria. We obtained a 10 g bend in the Nylon 6
(homopolymer) line, which had a diameter of 0.50 mm cut
at a length of 4 cm (Table 1). This result was confirmed in
100 consecutive tests by 2 different examiners (50 tests per
examiner), who used the thumb and index finger to hold the
line. This line used in the fabrication of fishing nets and rod
sport fishing (TREVO brand, Equipesca, SP-Brazil) and is
available in 250 g reels.
Phase 2: Chi-Square analysis of the 5 sites studied showed
that the individuals were incapable of differentiating
between the touch of the 2 filaments (p,0.05, Figure 1).
Phase 3: The patient analysis showed a satisfactory
concordance between answers for both monofilaments.
There was no difference in results at any site evaluated.
Correlation coefficients (k) confirmed the equivalence of
both nylon filaments with a variation of 0.96 to 1.00. This
value was 0.96¡0.02 (p,0.05) and 0.98¡0.01 (p,0.05) for
the right and left foot, respectively (Table 2).
DISCUSSION
The present study shows that it is possible to reduce the
cost of detecting ulcer risk of the foot in diabetic patients. In
the initial phase of the research we sought to find a fishing
line available in the nation market that had characteristics
similar to the 10 g internationally standardized monofila-
ment in terms of composition and bending. We subjected
these lines to evaluation of their physical and tonometric
characteristics. Non-diabetic individuals were not capable
of differentiating one monofilament from the other. A
previous study found similar results with a different line
that also reproduced the necessary characteristics.
12,20 When
we tested, in a patient-blind way, both monofilaments in
diabetic patients with and without neuropathy, we found
similar results. The kappa values revealed the strong
concordance of the lines. It is worth noting that the
population studied was multicentric, representative, and
homogeneous, with no demographic differences from other
local populations previously described.
21,22
Bourcier et al.
13 developed their fishing line instrument to
foment patient auto-examination. We had a very distinct
socioeconomic goal for addressing this public health
concern. Our study was conducted in a country with a
developing economy that has huge inter-regional, social,
and economic differences. Performing routine foot screen-
ing in the various health units in Brazil faces a lack of
capacitation and adequate material. Thus, with the excep-
tion of a few reference centers, the great majority of health
services across the country, particularly primary care units,
do not perform screening for the risk of diabetic foot.
Therefore, we are justified to repeat a study already done in
another country but with a line that is easy to obtain locally.
The present cost of the commercially available monofila-
ment is R$7.00 (USD 3.68) per unit (two lines in a kit). The
studied line is produced commercially on large scale for
exportation and is also sold all over the country. Its unit cost
is only R$0.00053 (USD 0.00029). The cost savings this line
may generate are significant, potentially allowing access to
this instrument at locations with few resources as well as
supporting its day-to-day use. Indirectly, it can also reduce
the costs of diabetic foot complications through early
detection.
The line was developed to not need any support
instruments. The examiner’s fingers act as the necessary
pincer. Any attempt to modify this technique, such as
Table 1 - Nylon lines and their respective bends in grams.
Line Commercial name Bend (grams)
0.40 Homopolymer TrevoH 0.40 4.6
0.50 Homopolymer TrevoH 0.50 10
0.50 Copolymer EkilonH cristal 0.50 7.2
0.60 Copolymer EkilonH cristal 0.60 14.3
0.70 Copolymer EkilonH cristal 0.70 24.1
Figure 1 - Percentage of rights and wrongs for both monofila-
ments in the non-diabetic population.
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1106fixation to paper or plastic, will alter the line’s physical
properties and, in so doing, will necessitate new studies. It is
also noteworthy that lines from other brands could also be
used, but similar studies are necessary to validate their
equivalence.
This study has its limitations. We used the same materials
to fabricate the monofilaments and all were made by the
same person. For large-scale use, caution should be taken in
regards to the line’s fabrication in order to avoid use of lines
of different brands and measures, preventing inadequate
accuracy. We also realize that in the present study there
were no new findings: a 10 g monofilament derived from a
fishing line performs as a 10-gram nylon monofilament.
However, at the public health policy level, this confirmation
was critical. The encouraging results of Bourcier et al. can be
expanded to include locally available materials.
CONCLUSION
We have demonstrated that a low cost instrument
developed from a fishing line is equivalent to instrument
used internationally to evaluate ulcer risk of the foot in
diabetic patients. It can be used as the standard line to
screening for diabetic neuropathy.
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